Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants

AIM: Direct‐acting oral anticoagulants (DOACs) have become available for the prevention of stroke in patients with atrial fibrillation (AF). Conflicting results have been published on the risk of acute myocardial infarction (AMI) with the use of DOACs in comparison with vitamin K antagonists (VKAs)....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Clin Pharmacol
Main Authors: Stolk, Leo M., de Vries, Frank, Ebbelaar, Chiel, de Boer, Anthonius, Schalekamp, Tom, Souverein, Patrick, ten Cate‐Hoek, Arina, Burden, Andrea M.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2017
Assuntos:
Pharmacoepidemiology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6495191/
https://ncbi.nlm.nih.gov/pubmed/28326589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13264
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados